the second generation antibodies may have a stronger binding affinity, more effective blocking of VEGF binding to VEGFR2, more specific blocking of VEGF binding to VEGFR2, even less blocking of VEGF binding to VEGFRl, enhanced ability to inhibit VEGF-induced proliferation and/or migration of endothelial cells, superior ability to inhibit VEGF-induced vascular permeability, and preferably, an increased ability to inhibit VEGF-induced angiogenesis in vivo, and to treat angiogenic diseases, including vascularized tumors
Although attention shifted after insulin was discovered, the mystery of the guts role in glucose regulation refused to die
GLP-1 secretion is increased by inflammatory stimuli in an IL-6dependent manner, leading to hyperinsulinemia and blood glucose lowering
Due to the disrupted metabolic processes, numerous signaling pathways become dysregulated, resulting in epigenetically induced inflammation